Cassava Sciences | PTIE - Equity Capital And Reserves

Stock Price
1.80
Daily Change
-0.11 -5.76%
Monthly
-15.49%
Yearly
-34.78%
Q1 Forecast
1.93

Cassava Sciences reported $74.4M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.13B 1.3B Dec/2025
Amgen USD 8.66B 961M Dec/2025
Biogen USD 18.21B 573.5M Sep/2025
Cara Therapeutics USD 32.93M 41M Jun/2025
Cassava Sciences USD 74.4M 7.16M Dec/2025
Eisai JPY 889.64B 35.21B Dec/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Geron USD 225.87M 22.83M Dec/2025
J&J USD 78.47B 0 Sep/2025
Merck USD 51.85B 2.79B Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Novavax USD -127.75M 28.92M Dec/2025
Pfizer USD 92.8B 4.11B Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025